Skip to Content Skip to Search
Production site Wavre
Production site Wavre

About us

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Every day, we help improve the health of millions of people around the world.

Our goal is to become one of the world’s most innovative, best performing and trusted healthcare companies.

What we do

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.


  • 99%

    of our vaccines are exported to over 160 countries

  • + 2 million

    doses of vaccines are produced every day


tablets on production line

Consumer Healthcare

Dentist and a patient

How we do it

Everyone at GSK is focused on our 3 long-term priorities – Innovation, Performance, Trust, all powered by our performance-focused culture.


Innovation is at the heart of delivering GSK’s purpose, by using our science to develop better medicines, vaccines, and consumer healthcare products. We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.


We deliver growth by investing effectively in our business, developing our people and executing competitively.


We are a responsible company – using our science and technology to address health needs, we are focused on making our products affordable and available and being a modern employer.

Belgium : the heart of GSK Vaccines

Belgium hosts 3 main vaccine sites for GSK (in Wavre, Rixensart and Gembloux), including the company's the global headquarters of the vaccines division of the group. This makes us the largest industrial network of vaccines in the world.

We ask each of our almost 9 000 employees working in Belgium to share our mission and to think about how they can help all those patients who rely on our products. For that reason, every day our 1,800 scientists research and develop vaccines. And that is why we have been pioneering new solutions allowing us to make our products available to those who need them, wherever they live and whatever their ability to pay.

Our history in Belgium

​GSK was formed in 2000 following the merger of Glaxo Wellcome plc and SmithKline Beecham plc, but our combined histories go back much further than that.

The very first predecessor of GSK, Plough Court Pharmacy, dates from 1715. Predecessors of GSK in Belgium made numerous discoveries in the 1930s and marketed medicines that are still considered as milestones in the history of healthcare.

Drawing of Plough Court Pharmacy in 1715

Our vaccine heritage goes back to Piet De Somer (who became the first rector of the of the KUL). Christian de Duve (future Nobel laureate) also worked as a research scientist. These two Belgians conducted the first research on penicillin and penicillin and antiviral vaccines vaccines as early as 1945.

The company R.I.T. (Recherche et Industrie Thérapeutique), founded by Pieter Desomer together with Christian de Duve in Genval and Rixensart, brought the life-saving medicine penicillin to the market.

GSK Code of Conduct

Our values and expectations are at the heart of everything we do. They define our code of conduct and guide all who work for or on behalf of GSK.

GSK Code of Conduct

Code Of Conduct PDF - 2,8MB

Anti-Bribery and Corruption (ABAC) Programme

Anti-Bribery and Corruption (ABAC) Programme

The Anti-Bribery and Corruption (ABAC) Programme is part of GSK’s response to the threat and risk of bribery and corruption. The programme includes the ABAC Handbook, which has been designed to assist internal and external parties understand corruption risk and identify people’s responsibilities to actively combat both real and perceived corruption.

GSK Anti-Bribery and Corruption Handbook PDF - 125,5KB

Anti-Bribery and Corruption Programme Third Party Guidelines

Anti-Bribery and Corruption Programme Third Party Guidelines

Third Party Guidelines are provided to all third parties that GSK engages with in order to make them aware of our anti-bribery and corruption policies and what we expect from them as our business partners

Working With Third Parties PDF - 332,2KB